Oruka Therapeutics, Inc. ORKA Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets?
- Oruka Therapeutics, Inc. (ORKA) reported increase (decrease) in prepaid expense and other assets of -$461K in Q1 2026.
- How has Oruka Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets changed year-over-year?
- Oruka Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets decreased by 411.5% year-over-year, from $148K to -$461K.
- What does increase (decrease) in prepaid expense and other assets mean?
- Measures the change in prepaid expenses and other short-term assets that have been paid for in advance but not yet recognized as expenses. A significant increase may indicate higher future cash outflows or changes in operational timing. This metric is a key component in calculating the net cash provided by operating activities.